Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia

다국어 초록 (Multilingual Abstract)

Galectins are an evolutionarily ancient and widely expressed family of lectins that have unique glycan-binding characteristics. They are pleiotropic regulators of key biological processes, such as cell growth, proliferation, differentiation, apoptosis, signal transduction, and pre-mRNA splicing, as well as homo- and heterotypic cell-cell and cell-extracellular matrix interactions. Galectins are also pivotal in immune responses since they regulate host-pathogen interactions, innate and adaptive immune responses, acute and chronic inflammation, and immune tolerance. Some galectins are also central to the regulation of angiogenesis, cell migration and invasion. Expression and functional data provide convincing evidence that, due to these functions, galectins play key roles in shared and unique pathways of normal embryonic and placental development as well as oncodevelopmental processes in tumorigenesis. Therefore, galectins may sometimes act as double-edged swords since they have beneficial but also harmful effects for the organism. Recent advances facilitate the use of galectins as biomarkers in obstetrical syndromes and in various malignancies, and their therapeutic applications are also under investigation. This review provides a general overview of galectins and a focused review of this lectin subfamily in the context of inflammation, infection and tumors of the female reproductive tract as well as in normal pregnancies and those complicated by the great obstetrical syndromes.

참고문헌 (Reference)

• 1 Blidner AG, "‘Sweetening’ pregnancy: galectins at the fetomaternal interface" 69 : 369-382, 2013
• 2 Fichorova RN, "vaginalis infection on innate immune responses and reproductive outcome" 83 : 185-189, 2009
• 3 Kim MJ, "Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection" 89 : 924-936, 2009
• 4 Douglas NC, "Vascular endothelial growth factor receptor 2(VEGFR-2)functions to promote uterine decidual angiogenesis during early pregnancy in the mouse" 150 : 3845-3854, 2009
• 5 Liu J, "Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein" 30 : 461-465, 2014
• 6 Segerer S, "Upregulation of chemokine and cytokine production during pregnancy" 67 : 145-150, 2009
• 7 Nickel W, "Unconventional secretory routes : direct protein export across the plasma membrane of mammalian cells" 6 : 607-614, 2005
• 8 Rabinovich GA, "Turning ‘sweet’ on immunity : galectin-glycan interactions in immune tolerance and inflammation" 9 : 338-352, 2009
• 9 Nicolaides KH, "Turning the pyramid of prenatal care" 29 : 183-196, 2011
• 10 Lahm H, "Tumor galectinology: insights into the complex network of a family of endogenous lectins" 20 : 227-238, 2004
• 11 Petty HR, "Trophoblast contact deactivates human neutrophils" 176 : 3205-3214, 2006
• 12 Smith LM, "Trichomonas vaginalis infection in a premature newborn" 22 : 502-503, 2002
• 13 Wang F, "Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+regulatory T cells" 214 : 342-349, 2009
• 14 Brosens I, "The"Great Obstetrical Syndromes"are associated with disorders of deep placentation" 204 : 193-201, 2011
• 15 Roberts JM, "The two stage model of preeclampsia: variations on the theme" 30 (30): S32-S37, 2009
• 16 Hassan SS, "The transcriptome of cervical ripening in human pregnancy before the onset of labor at term : identification of novel molecular functions involved in this process" 22 : 1183-1193, 2009
• 17 Gabius HJ, "The sugar code : functional lectinomics" 1572 : 165-177, 2002
• 18 Brosens IA, "The role of the spiral arteries in the pathogenesis of preeclampsia" 1 : 177-191, 1972
• 19 Sammar M, "The role of the carbohydrate recognition domain of placental protein 13 (PP13) in pregnancy evaluated with recombinant PP13 and the DelT221 PP13 variant" 9 : e102832-, 2014
• 20 Romero R, "The preterm parturition syndrome" 113 (113): 17-42, 2006
• 21 Romero R, "The preterm labor syndrome" 734 : 414-429, 1994
• 22 Hassan SS, "The molecular basis for sonographic cervical shortening at term: identification of differentially expressed genes and the epithelial-mesenchymal transition as a function of cervical length" 203 : 472.e1-472.e14, 2010
• 23 Mor G, "The immune system in pregnancy : a unique complexity" 63 : 425-433, 2010
• 24 Fridman WH, "The immune contexture in human tumours : impact on clinical outcome" 12 : 298-306, 2012
• 25 Bischof P, "The human cytotrophoblastic cell, a mononuclear chameleon" 37 : 1-16, 2005
• 26 Kim CJ, "The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth" 23 : 1000-1011, 2010
• 27 Toldi G, "The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25-FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia" 68 : 175-180, 2012
• 28 Hirabayashi J, "The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution" 3 : 297-304, 1993
• 29 Dong M, "The effect of trophoblasts on T lymphocytes : possible regulatory effector molecules : a proteomic analysis" 21 : 463-472, 2008
• 30 Zhu C, "The Tim-3 ligand galectin-9negatively regulates T helper type 1 immunity" 6 : 1245-1252, 2005
• 31 Yan-Hong Li, "The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal–fetal interface in early pregnancy" Springer Nature 13 (13): 73-81, 2015
• 32 Dalotto-Moreno T, "Targeting galectin-1overcomes breast cancer-associated immunosuppression and prevents metastatic disease" 73 : 1107-1117, 2013
• 33 Bastón JI, "Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis" 234 : 329-337, 2014
• 34 Kopcow HD, "T Cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1" 105 : 18472-18477, 2008
• 35 Ueda S, "Suppression of tumor growth by galectin-7 gene transfer" 64 : 5672-5676, 2004
• 36 von Dadelszen P, "Subclassification of preeclampsia" 22 : 143-148, 2003
• 37 Ferrer CM, "Sticking to sugars at the metastatic site : sialyltransferase ST6GalNAc2 acts as a breast cancer metastasis suppressor" 4 : 275-277, 2014
• 38 Lee VH, "Spatiotemporal pattern for expression of galectin-3 in the murine uteroplacental complex : evidence for differential regulation" 58 : 1277-1282, 1998
• 39 Venkatesha S, "Soluble endoglin contributes to the pathogenesis of preeclampsia" 12 : 642-649, 2006
• 40 Levine RJ, "Soluble endoglin and other circulating antiangiogenic factors in preeclampsia" 355 : 992-1005, 2006
• 41 Than NG, "Severe preeclampsia is characterized by increased placental expression of galectin-1" 21 : 429-442, 2008
• 42 Liang MY, "Serum galectin-9 in cervical cancer" 88 : 2783-2785, 2008
• 43 Barrow H, "Serum galectin-2, -4, and -8are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium" 17 : 7035-7046, 2011
• 44 Matsui Y, "Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species" 67 : 1212-1220, 2007
• 45 Swaminathan GJ, "Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 Å resolution" 38 : 13837-13843, 1999
• 46 Spencer K, "Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia" 27 : 258-263, 2007
• 47 Audibert F, "Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women" 203 : 383.e1-383.e8, 2010
• 48 Cuckle HS, "Screening for pre-eclampsia: lessons from aneuploidy screening" 32 (32): S42-S48, 2011
• 49 Vasta GR, "Roles of galectins in infection" 7 : 424-438, 2009
• 50 Zhu H, "Roles of galectin-7 and S100A9 in cervical squamous carcinoma : Clinicopathological and in vitro evidence" 132 : 1051-1059, 2013
• 51 Sato S, "Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia" 168 : 1813-1822, 2002
• 52 Omwandho CO, "Role of TGF-betas in normal human endometrium and endometriosis" 25 : 101-109, 2010
• 53 Burton GJ, "Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy" 30 : 473-482, 2009
• 54 Aluvihare VR, "Regulatory T cells mediate maternal tolerance to the fetus" 5 : 266-271, 2004
• 55 Liu AX, "Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss" 75 : 414-420, 2006
• 56 Webster RP, "Protein nitration in placenta : functional significance" 29 : 985-994, 2008
• 57 Sasaki Y, "Proportion of peripheral blood and decidual CD4(+)CD25(bright)regulatory T cells in pre-eclampsia" 149 : 139-145, 2007
• 58 Heusschen R, "Profiling Lgals9splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy" 88 : 22-, 2013
• 59 Kollar S, "Prevalence of intracellular galectin-1-expressing lymphocytes in umbilical cord blood in comparison with adult peripheral blood" 18 : 1608-1613, 2012
• 60 Romero R, "Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes" 72 : 458-474, 2014
• 61 Romero R, "Preterm labor: one syndrome, many causes" 345 : 760-765, 2014
• 62 Romero R, "Prenatal medicine: the child is the father of the man. 1996" 22 : 636-639, 2009
• 63 Bamberg C, "Prenatal diagnosis of fetal growth restriction" 9 : 387-394, 2004
• 64 Nelson JL, "Pregnancy, persistent microchimerism, and autoimmune disease" 53 : 31-32, 1998
• 65 Redman CW, "Preeclampsia: an excessive maternal inflammatory response to pregnancy" 180 (180): 499-506, 1999
• 66 Roberts JM, "Preeclampsia: an endothelial cell disorder" 161 : 1200-1204, 1989
• 67 Powe CE, "Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease" 123 : 2856-2869, 2011
• 68 Akolekar R, "Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks" 31 : 66-74, 2011
• 69 Sibai B, "Pre-eclampsia" 365 : 785-799, 2005
• 70 Than NG, "Placental protein 13(galectin-13)has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome" 453 : 387-400, 2008
• 71 Than NG, "Placental protein 13(PP13) : a placental immunoregulatory galectin protecting pregnancy" 5 : 348-, 2014
• 72 Huppertz B, "Placental protein 13(PP13) : a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia" 19 : 391-405, 2013
• 73 El Sherbiny WS, "Placental protein 13 as an early predictor in Egyptian patients with preeclampsia, correlation to risk, and association with outcome" 60 : 818-822, 2012
• 74 Gonen R, "Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study" 115 : 1465-1472, 2008
• 75 Kliman HJ, "Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia" 19 : 16-30, 2012
• 76 Balogh A, "Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome" 205 : 156.e1-156.e14, 2011
• 77 Burger O, "Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies" 25 : 608-622, 2004
• 78 Burton GJ, "Placental oxidative stress : from miscarriage to preeclampsia" 11 : 342-352, 2004
• 79 Rusterholz C, "Placental microparticles, DNA, and RNA in preeclampsia" 30 : 364-375, 2011
• 80 Burton GJ, "Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia" 30 (30): S43-S48, 2009
• 81 Sammar M, "Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery" 32 (32): S30-S36, 2011
• 82 Houzelstein D, "Phylogenetic analysis of the vertebrate galectin family" 21 : 1177-1187, 2004
• 83 Mazurek N, "Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells" 282 : 21337-21348, 2007
• 84 Gervasi MT, "Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia" 185 : 792-797, 2001
• 85 Naccasha N, "Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection" 185 : 1118-1123, 2001
• 86 Gervasi MT, "Phenotypic and metabolic characteristics of maternal monocytes and granulo cytes in preterm labor with intact membranes" 185 : 1124-1129, 2001
• 87 Doverhag C, "Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice" 31 : 133-144, 2008
• 88 Molvarec A, "Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia" 139 : 48-56, 2011
• 89 Meggyes M, "Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy" 9 : e92371-, 2014
• 90 Xu Y, "Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis" 67 : 184-197, 2012
• 91 Farina A, "Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks" 203 : 575.e1-575.e7, 2010
• 92 Benirschke K, "Pathology of the human placenta" Springer-Verlag 2006
• 93 Than NG, "PP13, maternal ABO blood groups and the risk assessment of pregnancy complications" 6 : e21564-, 2011
• 94 Sekizawa A, "PP13 mRNA expression in trophoblasts from preeclamptic placentas" 16 : 408-413, 2009
• 95 Shimizu H, "PP13 mRNA expres sion in the cellular component of maternal blood as a marker for preeclampsia" 29 : 1231-1236, 2009
• 96 Moslemi Zadeh N, "PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?" 2012 : 263871-, 2012
• 97 Rusterholz C, "Oxidative stress alters the integrity of cell-free mRNA fragments associated with placenta-derived syncytiotrophoblast microparticles" 22 : 313-317, 2007
• 98 Demers M, "Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells" 176 : 3023-3031, 2010
• 99 Kim MK, "Overexpression of galectin-3 and its clinical significance in ovarian carcinoma" 16 : 352-358, 2011
• 100 Correa SG, "Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages" 13 : 119-128, 2003
• 101 Apweiler R, "On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database" 1473 : 4-8, 1999
• 102 Varki A., "Nothing in glycobiology makes sense, except in the light of evolution" 126 : 841-845, 2006
• 103 Sacks GP, "Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis" 179 : 80-86, 1998
• 104 Guha P, "Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, alpha9 nicotinic acetylcholine receptor and STAT3" 145 : 5-22, 2014
• 105 Hahn S, "Neutrophil NETs in reproduction : from infertility to preeclampsia and the possibility of fetal loss" 3 : 362-, 2012
• 106 Borghese B, "Neurotrophins and pain in endometriosis" 38 : 442-446, 2010
• 107 Soker S, "Neuropilin-1 is expressed by endothelial and tumor cells as an isoformspecific receptor for vascular endothelial growth factor" 92 : 735-745, 1998
• 108 Karimi K, "Natural killer cells: keepers of pregnancy in the turnstile of the environment" 24 : 339-347, 2010
• 109 Mylonas I, "Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma:an immunohistochemical analysis" 27 : 1975-1980, 2007
• 110 Shankar R, "Molecular markers of preterm labor in the choriodecidua" 17 : 297-310, 2010
• 111 Redman CW, "Microparticles and immunomodulation in pregnancy and pre-eclampsia" 76 : 61-67, 2007
• 112 Savman K, "Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia" 4 : 228-235, 2013
• 113 DiGiulio DB, "Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation" 3 : e3056-, 2008
• 114 Dennis JW, "Metabolism, cell surface orga nization, and disease" 139 : 1229-1241, 2009
• 115 Baptiste TA, "Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells : implications in the extracellular functions of the lectin" 313 : 652-664, 2007
• 116 Akolekar R, "Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia" 29 : 1103-1108, 2009
• 117 Gervasi MT, "Maternal intravascular inflammation in preterm premature rupture of membranes" 11 : 171-175, 2002
• 118 Lee J, "Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis : evidence in support of the chronic nature of maternal anti-fetal rejection" 66 : 510-526, 2011
• 119 Lee JH, "Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary: an annealing control primer system and immunohistochemical study" 41 : 229-233, 2009
• 120 Khaldoyanidi SK, "MDA-MB-435 human breast carcinoma cell homo-and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions" 278 : 4127-4134, 2003
• 121 Huppertz B, "Longitudinal determination of serum placental protein 13during development of preeclampsia" 24 : 230-236, 2008
• 122 Irgens HU, "Long term mortality of mothers and fathers after pre-eclampsia : population based cohort study" 323 : 1213-1217, 2001
• 123 Danielsen EM, "Lipid raft organization and function in brush borders of epithelial cells" 23 : 71-79, 2006
• 124 Caserta D, "Levels of galectin-3 and stimulation expressed gene 2 in the peritoneal fluid of women with endometriosis : a pilot study" 30 : 877-880, 2014
• 125 Ogge G, "Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia" 23 : 476-487, 2010
• 126 Lima PD, "Leukocyte driven-decidual angiogenesis in early pregnancy" 11 : 522-537, 2014
• 127 Redman CW, "Latest advances in understanding preeclampsia" 308 : 1592-1594, 2005
• 128 Than NG, "Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein" 20 : 703-710, 1999
• 129 Miko E, "Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia" 8 : e71811-, 2013
• 130 Ege CB, "Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival" 284 : 1231-1239, 2011
• 131 Liu FT, "Intracellular functions of galectins" 1572 : 263-273, 2002
• 132 Freitag N, "Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia" 110 : 11451-11456, 2013
• 133 Stowell SR, "Innate immune lectins kill bacteria expressing blood group antigen" 16 : 295-301, 2010
• 134 Choi JH, "Inhibition of N-(4-hydroxyphenyl) retinamide-induced apoptosis in breast cancer cells by galectin-3" 3 : 447-452, 2004
• 135 Gil CD, "Inflammation-induced modulation of cellular galectin-1 and-3 expression in a model of rat peritonitis" 55 : 99-107, 2006
• 136 Romero R, "Inflammation in preterm and term labour and delivery" 11 : 317-326, 2006
• 137 Gupta AK, "Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia" 66 : 1146-1154, 2005
• 138 Park JE, "Induction of matrix metalloprotein ase-9 by galectin-7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells" 22 : 1373-1379, 2009
• 139 Gauthier S, "Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity" 5 : 105-, 2008
• 140 Kohrenhagen N, "Increased expression of galectin-1 during the progression of cervical neoplasia" 16 : 2018-2022, 2006
• 141 Saito S, "Inadequate tolerance induction may induce pre-eclampsia" 76 : 30-39, 2007
• 142 Lapaire O, "Impact of fetalmaternal microchimerism on women’s health : a review" 20 : 1-5, 2007
• 143 Matthiesen L, "Immunology of preeclampsia" 89 : 49-61, 2005
• 144 Redman CW, "Immunology of pre-eclampsia" 63 : 534-543, 2010
• 145 Moffett A, "Immunology of placentation in eutherian mammals" 6 : 584-594, 2006
• 146 Hammer A, "Immunological regulation of trophoblast invasion" 90 : 21-28, 2011
• 147 Eis AL, "Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes" 38 : 289-294, 1997
• 148 Danguy A, "Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system" 16 : 861-868, 2001
• 149 Walzel H, "Immunohistochemical and glycohistochemical localization of the beta-galactoside-binding Stype lectin in human placenta" 97 : 33-42, 1995
• 150 Lebovic DI, "Immunobiology of endometriosis" 75 : 1-10, 2001
• 151 Erlebacher A., "Immune surveillance of the maternal/fetal interface:controversies and implications" 21 : 428-434, 2010
• 152 Dagher SF, "Identification of galectin-3 as a factor in pre-mRNA splicing" 92 : 1213-1217, 1995
• 153 Redman CW, "IFPA Senior Award Lecture:making sense of pre-eclampsia - two placental causes of preeclampsia?" 35 (35): S20-S25, 2014
• 154 Ahmed MS, "IFPA Meeting 2012 Workshop Report II: epigenetics and imprinting in the placenta, growth factors and villous trophoblast differentiation, role of the placenta in regulating fetal exposure to xenobiotics during pregnancy, infection and the placenta" 34 (34): S6-S10, 2013
• 155 Knӧfler M, "IFPA Award in Placentology lecture: molecular regulation of human trophoblast invasion" 33 (33): S55-S62, 2012
• 156 Knöfler M, "Human placental trophoblast invasion and differentiation : a particular focus on Wnt signaling" 4 : 190-, 2013
• 157 Saal I, "Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization" 20 : 1191-1208, 2005
• 158 Koopman LA, "Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential" 198 : 1201-1212, 2003
• 159 Yang H, "Human chorionic gonadotropin(hCG)regulation of galectin-3 expression in endometrial epithelial cells and endometrial stromal cells" 115 : 3-7, 2013
• 160 Kubach J, "Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function" 110 : 1550-1558, 2007
• 161 Visegrády B, "Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)" 14 : 875-880, 2001
• 162 Ness RB, "Heterogeneous causes constituting the single syndrome of preeclampsia : a hypothesis and its implications" 175 : 1365-1370, 1996
• 163 Than NG, "Handbook of growth and growth monitoring in health and disease" Springer 1867-1891, 2012
• 164 Sutton L, "HLA-DR positive cells in the human placenta" 49 : 103-112, 1983
• 165 López-Lucendo MF, "Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding" 343 : 957-970, 2004
• 166 Liang CH, "Glycan array : a powerful tool for glycomics studies" 6 : 631-645, 2009
• 167 Kasai K, "Galectins: a family of animal lectins that decipher glycocodes" 119 : 1-8, 1996
• 168 Barondes SH, "Galectins. Structure and function of a large family of animal lectins" 269 : 20807-20810, 1994
• 169 Griffioen AW, "Galectins in tumor angiogenesis" 2 : 90-, 2014
• 170 Sato S, "Galectins in innate immunity : dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns(DAMPs)and as receptors for pathogen-associated molecular patterns(PAMPs)" 230 : 172-187, 2009
• 171 Ebrahim AH, "Galectins in cancer: carcinogenesis, diagnosis and therapy" 2 : 88-, 2014
• 172 Blois SM, "Galectins in angiogenesis : consequences for gestation" 108 : 33-41, 2015
• 173 Liu FT, "Galectins as modulators of tumour progression" 5 : 29-41, 2005
• 174 Moiseeva EV, "Galectins as markers of aggressiveness of mouse mammary carcinoma : towards a lectin target therapy of human breast cancer" 91 : 227-241, 2005
• 175 Rabinovich GA, "Galectins as immunoregulators during infectious processes : from microbial invasion to the resolution of the disease" 27 : 103-114, 2005
• 176 Balan V, "Galectins as cancer biomarkers" 2 : 592-610, 2010
• 177 Chen HL, "Galectins and neuroinflammation" 9 : 517-542, 2014
• 178 Liu FT, "Galectins : regulators of acute and chronic inflammation" 1183 : 158-182, 2010
• 179 Than NG, "Galectins : guardians of eutherian pregnancy at the maternalfetal interface" 23 : 23-31, 2012
• 180 Cooper DN, "Galectinomics : finding themes in complexity" 1572 : 209-231, 2002
• 181 Heusschen R, "Galectin-9 in tumor biology : a jack of multiple trades" 1836 : 177-185, 2013
• 182 Irie A, "Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer" 11 : 2962-2968, 2005
• 183 Popovici RM, "Galectin-9 : a new endometrial epithelial marker for the mid-and late-secretory and decidual phases in humans" 90 : 6170-6176, 2005
• 184 Kolundžic’ N, "Galectin-8 is expressed by villous and extravillous trophoblast of the human placenta" 32 : 909-911, 2011
• 185 Tsai CJ, "Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix" 131 : 645-649, 2013
• 186 Saussez S, "Galectin-7" 63 : 686-697, 2006
• 187 Moon BK, "Galectin-3protects human breast carcinoma cells against nitric oxide-induced apoptosis : implication of galectin-3 function during metastasis" 159 : 1055-1060, 2001
• 188 Fowler M, "Galectin-3binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion" 8 : 44-54, 2006
• 189 Yu F, "Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria : a role for synexin in galectin-3 translocation" 277 : 15819-15827, 2002
• 190 Inohara H, "Galectin-3 stimulates cell proliferation" 245 : 294-302, 1998
• 191 Matarrese P, "Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis" 473 : 311-315, 2000
• 192 Oishi T, "Galectin-3 may contribute to cisplatin resistance in clear cell carcinoma of the ovary" 17 : 1040-1046, 2007
• 193 Noël JC, "Galectin-3 is overexpressed in various forms of endometriosis" 19 : 253-257, 2011
• 194 Yu LG, "Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007; 282:773-81" 282 : 773-781, 2007
• 195 Balasubramanian K, "Galectin-3 in urine of cancer patients: stage and tissue specificity" 135 : 355-363, 2009
• 196 Demmert M, "Galectin-3 in cord blood of term and preterm infants" 167 : 246-251, 2012
• 197 Song L, "Galectin-3 in cancer" 431 : 185-191, 2014
• 198 Stewart CJ, "Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion" 29 : 555-561, 2010
• 199 Brustmann H, "Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues" 199 : 151-158, 2003
• 200 Lin HM, "Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells" 21 : 8001-8010, 2002
• 201 Nangia-Makker P, "Galectin-3 cleavage : a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers" 67 : 11760-11768, 2007
• 202 John CM, "Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected" 4 : 649-662, 2002
• 203 Dumic J, "Galectin-3 : an open-ended story" 1760 : 616-635, 2006
• 204 Akahani S, "Galectin-3 : a novel antiapoptotic molecule with a functional BH1(NWGR)domain of Bcl-2 family" 57 : 5272-5276, 1997
• 205 Elola MT, "Galectin-1receptors in different cell types" 12 : 13-29, 2005
• 206 Camby I, "Galectin-1: a small protein with major functions" 16 : 137R-157R, 2006
• 207 Garin MI, "Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells" 109 : 2058-2065, 2007
• 208 Fulcher JA, "Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix" 177 : 216-226, 2006
• 209 Hsieh SH, "Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells" 27 : 3746-3753, 2008
• 210 Mercier S, "Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption" 371 : 121-129, 2008
• 211 Vergetaki A, "Galectin-1 overexpression in endometriosis and its regulation by neuropeptides (CRH, UCN) indicating its important role in reproduction and inflammation" 9 : e114229-, 2014
• 212 Okumura CY, "Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis" 10 : 2078-2090, 2008
• 213 Kolundžic’ N, "Galectin-1 is part of human trophoblast invasion machinery:a functional study in vitro" 6 : e28514-, 2011
• 214 Thijssen VL, "Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy" 103 : 15975-15980, 2006
• 215 Huang EY, "Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix" 87 : 975-982, 2013
• 216 Tirado-González I, "Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy" 19 : 43-53, 2013
• 217 Jung EJ, "Galectin-1 expression in cancerassociated stromal cells correlates tumor invasiveness and tumor progression in breast cancer" 120 : 2331-2338, 2007
• 218 Rabinovich GA, "Galectin-1 as a potential cancer target" 92 : 1188-1192, 2005
• 219 Vicovac L, "Galectin-1 and-3 in cells of the first trimester placental bed" 13 : 730-735, 1998
• 220 Bozic’ M, "Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease" 25 : 797-802, 2004
• 221 Ouellet M, "Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells" 174 : 4120-4126, 2005
• 222 van den Brule F, "Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin" 83 : 377-386, 2003
• 223 Blois SM, "Galectin signature in normal pregnancy and preeclampsia" 101-102 : 127-134, 2014
• 224 Chiariotti L, "Galectin genes : reg ulation of expression" 19 : 441-449, 2004
• 225 von Wolff M, "Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation" 11 : 189-194, 2005
• 226 Lewis SK, "Galectin 15(LGALS15) : a gene uniquely expressed in the uteri of sheep and goats that functions in trophoblast attachment" 77 : 1027-1036, 2007
• 227 Kim HJ, "Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer" 44 : 62-68, 2013
• 228 Than NG, "Functional analyses of placental protein 13/galectin-13" 271 : 1065-1078, 2004
• 229 Myatt L, "First-trimester prediction of preeclampsia in nulliparous women at low risk" 119 : 1234-1242, 2012
• 230 Odibo AO, "First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia" 32 : 598-602, 2011
• 231 Chafetz I, "First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction" 197 : 35.e1-35.e7, 2007
• 232 Wortelboer EJ, "First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia" 117 : 1384-1389, 2010
• 233 Romero R, "First-trimester maternal serum PP13 in the risk assessment for preeclampsia" 199 : 122.e1-122.e11, 2008
• 234 Spencer K, "First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia" 29 : 128-134, 2007
• 235 Khalil A, "First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk" 35 : 671-679, 2010
• 236 Schneuer FJ, "First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age : in-house study and systematic review" 33 : 735-740, 2012
• 237 Svirsky R, "First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia" 41 : 561-566, 2013
• 238 Khalil A, "First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk" 29 : 781-789, 2009
• 239 Di Lorenzo G, "First trimester maternal serum PIGF, free beta-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia" 33 : 495-501, 2012
• 240 Arck PC, "Fetomaternal immune cross-talk and its consequences for maternal and offspring’s health" 19 : 548-556, 2013
• 241 Barker DJ, "Fetal nutrition and cardiovascular disease in later life" 53 : 96-108, 1997
• 242 Arikawa T, "Expression pattern of Galectin 4 in rat placentation" 33 : 885-887, 2012
• 243 Baston-Buest DM, "Expression of the vascular endothelial growth factor receptor neuropilin-1 at the human embryo-maternal interface" 154 : 151-156, 2011
• 244 van den Brule FA, "Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma" 27 : 1185-1191, 1996
• 245 Campion CG, "Expression of galectin-7 is induced in breast cancer cells by mutant p53" 8 : e72468-, 2013
• 246 Yang RY, "Expression of galectin-3 modulates T-cell growth and apoptosis" 93 : 6737-6742, 1996
• 247 Yang H, "Expression of galectin-3 in mouse endometrium and its effect during embryo implantation" 24 : 116-122, 2012
• 248 Jeschke U, "Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas" 28 : 1165-1173, 2007
• 249 Choe YS, "Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation" 48 : 261-266, 1997
• 250 Shimizu Y, "Expression and localization of galectin-9 in the human uterodome" 55 : 879-887, 2008
• 251 Labrie M, "Expression and functions of galectin-7 in ovarian cancer" 5 : 7705-7721, 2014
• 252 Jeschke U, "Expression and function of galectins in the endometrium and at the human feto-maternal interface" 34 : 863-872, 2013
• 253 Maynard SE, "Excess placental soluble fmslike tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia" 111 : 649-658, 2003
• 254 Than NG, "Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia" 35 : 855-865, 2014
• 255 Wildman DE, "Evolution of the mammalian placenta revealed by phylogenetic analysis" 103 : 3203-3208, 2006
• 256 Chaiworapongsa T, "Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award" 190 : 1541-1547, 2004
• 257 Kuc S, "Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia : a systematic review" 66 : 225-239, 2011
• 258 Cummings RD, "Essentials of glycobiology" Cold Spring Harbor Laboratory Press 475-488, 2009
• 259 Varki A, "Essentials in glycobiology" Cold Spring Harbor Laboratory Press 2008
• 260 Goldenberg RL, "Epidemiology and causes of preterm birth" 371 : 75-84, 2008
• 261 Burton GJ, "Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia" 1 : 72-78, 2011
• 262 Than NG, "Emergence of hormonal and redox regulation of galectin-1 in placental mammals : implication in maternal-fetal immune tolerance" 105 : 15819-15824, 2008
• 263 Colnot C, "Embryonic implantation in galectin 1/galectin 3 double mutant mice" 211 : 306-313, 1998
• 264 Kasamatsu A, "Elevation of galectin-9as an inflammatory response in the periodontal ligament cells exposed to Porphylomonas gingivalis lipopolysaccharide in vitro and in vivo" 37 : 397-408, 2005
• 265 Gizurarson S, "Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents" 33 : 257-264, 2013
• 266 Grimpel YI, "Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants" 32 (32): S55-S64, 2011
• 267 Li H, "Effect of ex vivo-expanded γδ-T cells combined with galectin-1 antibody on the growth of human cervical cancer xenografts in SCID mice" 33 : E280-E289, 2010
• 268 Lee X, "Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia" 22 : 808-812, 2001
• 269 Honjo Y, "Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells" 7 : 661-668, 2001
• 270 Toscano MA, "Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death" 8 : 825-834, 2007
• 271 Phillips B, "Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice" 55 : 548-558, 1996
• 272 van den Brule FA, "Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis" 209 : 399-405, 1997
• 273 Halder JB, "Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164)in vascular permeability and angiogenesis during implantation" 26 : 213-224, 2000
• 274 Carlsson MC, "Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease" 1820 : 1366-1372, 2012
• 275 Aplin JD, "Developmental cell biology of human villous trophoblast : current research problems" 54 : 323-329, 2010
• 276 Horlacher T, "Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays" 11 : 1563-1573, 2010
• 277 Lee J, "Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery" 70 : 162-175, 2013
• 278 Chen CP, "Decreased placental GCM1(glial cells missing)gene expression in pre-eclampsia" 25 : 413-421, 2004
• 279 Lee JW, "Decreased galectin-3 expression during the progression of cervical neoplasia" 132 : 241-247, 2006
• 280 Godbole G, "Decidualized endometrial stromal cell derived factors promote trophoblast invasion" 95 : 1278-1283, 2011
• 281 Bianchi ME, "DAMPs, PAMPs and alarmins: all we need to know about danger" 81 : 1-5, 2007
• 282 Grosset AA, "Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells" 14 : 801-, 2014
• 283 Bianchi DW, "Current knowledge about fetal blood cells in the maternal circulation" 26 : 175-185, 1998
• 284 Crider-Pirkle S, "Cubilin, a binding partner for galectin-3 in the murine utero-placental complex" 277 : 15904-15912, 2002
• 285 Sundqvist M, "Cord blood neutrophils display a galectin-3 responsive phenotype accentuated by vaginal delivery" 13 : 128-, 2013
• 286 Iurisci I, "Concentrations of galectin-3 in the sera of normal controls and cancer patients" 6 : 1389-1393, 2000
• 287 Kim SS, "Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo plasticity of chorioamniotic mesodermal cells of the human placenta" 88 : 365-374, 2008
• 288 Yang QS, "Cloning and expression of a novel human galectin cDNA, predominantly expressed in placenta" 1574 : 407-411, 2002
• 289 Nangia-Makker P, "Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer" 127 : 2530-2541, 2010
• 290 Min KW, "Clear cell carcinomas of the ovary : a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and galectin-3" 32 : 3-14, 2013
• 291 Redman CW, "Circulating microparticles in normal pregnancy and pre-eclampsia" 29 (29): S73-S77, 2008
• 292 Chen C, "Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis" 110 : 741-752, 2014
• 293 Ogge G, "Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome" 223 : 553-565, 2011
• 294 Than NG, "Chorioamnionitis and increased galectin-1 expression in PPROM: an anti-inflammatory response in the fetal membranes?" 60 : 298-311, 2008
• 295 Ryan CM, "Chemical structure of Trichomonas vaginalis surface lipoglycan : a role for short galactose(beta1-4/3)N-acetylglucosamine repeats in host cell interaction" 286 : 40494-40508, 2011
• 296 Nhan-Chang CL, "Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term" 202 : 462.e1-462.e41, 2010
• 297 Mittal P, "Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term" 38 : 617-643, 2010
• 298 Lee J, "Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection : evidence of a distinct and novel type of human fetal systemic inflammatory response" 70 : 265-284, 2013
• 299 Kim HR, "Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells" 59 : 4148-4154, 1999
• 300 Nangia-Makker P, "Carbohydrate-recognition and angiogenesis" 19 : 51-57, 2000
• 301 Fukumori T, "CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis" 63 : 8302-8311, 2003
• 302 Logullo AF, "C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer" 18 : 121-126, 2007
• 303 Brewer FC, "Binding and cross-linking properties of galectins" 1572 : 255-262, 2002
• 304 Barondes SH, "Bifunctional properties of lectins : lectins redefined" 13 : 480-482, 1988
• 305 Jerzak M, "Apoptosis in the first trimester human placenta:the role in maintaining immune privilege at the maternalfoetal interface and in the trophoblast remodelling" 100 : 138-142, 2002
• 306 Espinoza J, "Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes" 13 : 2-21, 2003
• 307 Hernandez JD, "Ah, sweet mystery of death! Galectins and control of cell fate" 12 : 127R-136R, 2002
• 308 Than GN, "Advances in pregnancy-related protein research: functional and clinical applications" CRC Press 1993
• 309 Hepojoki J, "Acute hantavirus infection induces galectin-3-binding protein" 95 (95): 2356-2364, 2014
• 310 ACOG Committee on Practice Bulletins--Obstetrics, "ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002" 99 : 159-167, 2002
• 311 Lee J, "A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d" 6 : e16806-, 2011
• 312 Than NG, "A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death" 106 : 9731-9736, 2009
• 313 Blois SM, "A pivotal role for galectin-1 in fetomaternal tolerance" 13 : 1450-1457, 2007
• 314 Huang EY, "A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells" 3 : e251-, 2012
• 315 Barrionuevo P, "A novel function for galectin-1 at the crossroad of innate and adaptive immunity:galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway" 178 : 436-445, 2007
• 316 Gebhardt S, "A novel exonic variant(221delT)in the LGALS13 gene encoding placental protein 13(PP13)is associated with preterm labour in a low risk population" 82 : 166-173, 2009
• 317 Nicolaides KH, "A novel approach to firsttrimester screening for early pre-eclampsia combining serum PP-13and Doppler ultrasound" 27 : 13-17, 2006
• 318 Su AI, "A gene atlas of the mouse and human protein-encoding transcriptomes" 101 : 6062-6067, 2004
• 319 Mazurek N, "A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells" 117 : 4375-4380, 2011
• 320 St-Pierre Y, "A distinctive role for galectin-7 in cancer?" 17 : 438-450, 2012